Magnesium Implants Release Hydrogen to Fight Ovarian Cancer

Authors
Journal
ACS Biomaterials Science & Engineering
Year
DOI
10.1021/acsbiomaterials.9b01703
Study Type
Mouse
Outcome
Positive
Peer Reviewed
Yes
Country
China
Health Condition
Epithelial Ovarian Cancer
Body System
Reproductive System

TL;DR

High-purity magnesium wires show potential as a treatment for ovarian cancer by inhibiting tumor growth and promoting cancer cell death.

Key Finding

Biodegradable magnesium implants and their breakdown products significantly inhibited ovarian cancer cell growth and promoted cancer cell death in mouse models and laboratory experiments.

Summary

Researchers tested whether magnesium implants (small metal devices that break down in the body) could slow the growth of ovarian cancer cells. Using mouse models and lab experiments, they found that magnesium implants and their breakdown products—including magnesium ions and hydrogen gas—reduced cancer cell growth and triggered cancer cell death. The results suggest magnesium implants might one day help treat ovarian cancer, especially in cases where chemotherapy drugs stop working.

Practical Takeaway

This is early-stage research in mice and lab dishes, not yet tested in humans. While the results are promising for a potential future cancer treatment, it's far too preliminary to draw any conclusions about hydrogen water or magnesium supplements for ovarian cancer. Many promising laboratory findings do not translate to human benefit, and anyone with ovarian cancer should discuss treatment options only with their oncologist.

Abstract (excerpt)

The common treatment of epithelial ovarian cancer is aggressive surgery followed by platinum-based cytotoxic chemotherapy. However, residual tumor cells are resistant to chemotherapeutic drugs during postoperative recurrence. The treatment of ovarian cancer requires new breakthroughs and advances…

Read the full abstract via DOI